
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $3M | -- | -- | |
Selling, General & Admin | $8.9K | $14.7K | $183.7K | $64.8K | $95.8K | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $8.9K | $14.7K | $3.2M | $64.8K | $95.8K | |
Operating Income | -$8.9K | -$14.7K | -$3.2M | -$64.8K | -$95.8K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$8.9K | -$14.7K | -$3.2M | -$64.8K | -$95.8K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$8.9K | -$14.7K | -$3.2M | -$64.8K | -$95.8K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$8.9K | -$14.7K | -$3.2M | -$64.8K | -$95.8K | |
Basic EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -- | |
Diluted EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -- | |
Weighted Average Basic Share | $876.1M | $876.1M | $876.1M | $876.1M | $1B | |
Weighted Average Diluted Share | $876.1M | $876.1M | $876.1M | $876.1M | $1B | |
EBITDA | -$8.9K | -$14.7K | -$3.2M | -$64.8K | -$95.8K | |
EBIT | -$8.9K | -$14.7K | -$3.2M | -$64.8K | -$95.8K | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$8.9K | -$14.7K | -$3.2M | -$64.8K | -$95.8K | |
Operating Income (Adjusted) | -$8.9K | -$14.7K | -$3.2M | -$64.8K | -$95.8K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.8K | $6.3K | $19.6K | $46K | $13K | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $5.8K | $6.3K | $19.6K | $46K | $13K | |
Operating Income | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Basic EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -- | -- | |
Diluted EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -- | -- | |
Weighted Average Basic Share | $876.1M | $876.1M | $876.1M | $876.1M | $1B | |
Weighted Average Diluted Share | $876.1M | $876.1M | $876.1M | $876.1M | $1B | |
EBITDA | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
EBIT | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Operating Income (Adjusted) | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $14.7K | $15.3K | $197K | $91.2K | $88.7K | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $14.7K | $15.3K | $3.2M | $91.2K | $88.7K | |
Operating Income | -$14.7K | -$15.3K | -$3.2M | -$91.2K | -$88.6K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$14.7K | -$15.3K | -$3.2M | -$91.2K | -$88.6K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$15.3K | -$3.2M | -$91.2K | -$62.8K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$14.7K | -$15.3K | -$3.2M | -$91.2K | -$88.6K | |
Basic EPS (Cont. Ops) | -- | -- | -$0.00 | -$0.00 | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.00 | -$0.00 | -- | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$14.7K | -$15.3K | -$3.2M | -$91.2K | -$88.6K | |
EBIT | -$14.7K | -$15.3K | -$3.2M | -$91.2K | -$88.6K | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$14.7K | -$15.3K | -$3.2M | -$91.2K | -$88.6K | |
Operating Income (Adjusted) | -$14.7K | -$15.3K | -$3.2M | -$91.2K | -$88.6K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.8K | $6.3K | $19.6K | $46K | $13K | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $5.8K | $6.3K | $19.6K | $46K | $13K | |
Operating Income | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Basic EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -- | -- | |
Diluted EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -- | -- | |
Weighted Average Basic Share | $876.1M | $876.1M | $876.1M | $876.1M | $1B | |
Weighted Average Diluted Share | $876.1M | $876.1M | $876.1M | $876.1M | $1B | |
EBITDA | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
EBIT | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Operating Income (Adjusted) | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.6K | $400 | $860 | $19.6K | $2.1K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | $15.9K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.6K | $400 | $860 | $19.6K | $17.9K | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $1.6K | $400 | $860 | $19.6K | $17.9K | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | $10.5K | $18.2K | $101.8K | $239.2K | |
Long-Term Debt | $10.5K | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $10.5K | $24K | $18.2K | $101.8K | $239.2K | |
Common Stock | $13.2K | $39.6K | $88.6K | $88.6K | $103.7K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -$8.9K | -$23.6K | -$18.3K | -$83.2K | -$222.7K | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$8.9K | -$23.6K | -$17.3K | -$82.2K | -$221.2K | |
Total Liabilities and Equity | $1.6K | $400 | $860 | $19.6K | $17.9K | |
Cash and Short Terms | $1.6K | $400 | $860 | $19.6K | $2.1K | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.4K | $80 | $4.5K | $24.5K | $19.1K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | $17K | -- | |
Prepaid Expenses | -- | -- | -- | -- | $15.9K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.4K | $80 | $4.5K | $41.5K | $35K | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $1.4K | $80 | $4.5K | $41.5K | $35K | |
Accounts Payable | -- | -- | -- | $9.3K | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | $41.4K | $266K | $269.2K | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $16K | -- | $41.4K | $266K | $269.2K | |
Common Stock | $13.2K | $13.2K | $88.6K | $88.6K | $104.1K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$14.7K | $80 | -$36.9K | -$224.5K | -$234.2K | |
Total Liabilities and Equity | $1.4K | $80 | $4.5K | $41.5K | $35K | |
Cash and Short Terms | $1.4K | $80 | $4.5K | $24.5K | $19.1K | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$8.9K | -$14.7K | -$3.2M | -$64.8K | -$95.8K | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$8.9K | -$14.7K | -$33.7K | -$64.8K | -$139.1K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $10.5K | $13.5K | $24.2K | $83.6K | $137.4K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $10.5K | $13.5K | $34.2K | $83.6K | $137.4K | |
Beginning Cash (CF) | -- | $1.6K | $400 | $860 | $19.6K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.6K | -$1.2K | $470 | $18.7K | -$17.5K | |
Ending Cash (CF) | $1.6K | $400 | $860 | $19.6K | $2.1K | |
Levered Free Cash Flow | -$8.9K | -$14.7K | -$33.7K | -$64.8K | -$139.1K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$5.8K | -$6.3K | -$19.6K | -$84.4K | -$13K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $5.5K | $6K | $23.2K | $99K | $30K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $5.5K | $6K | $23.2K | $99K | $30K | |
Beginning Cash (CF) | $1.6K | $400 | $860 | $4.9K | $2.1K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$250 | -$320 | $3.6K | $14.7K | $17.1K | |
Ending Cash (CF) | $1.4K | $80 | $4.5K | $19.6K | $19.1K | |
Levered Free Cash Flow | -$5.8K | -$6.3K | -$19.6K | -$84.3K | -$12.9K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$15.3K | -$3.2M | -$91.2K | -$62.8K | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$14.7K | -$15.3K | -$47K | -$129.6K | -$67.7K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $16K | $14K | $41.3K | $159.4K | $68.4K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $16K | $14K | $51.3K | $159.4K | $68.4K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$1.3K | $4.4K | $29.9K | -$15.2K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$14.7K | -$15.3K | -$47K | -$129.6K | -$67.7K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$5.8K | -$6.3K | -$19.6K | -$46K | -$13K | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$5.8K | -$6.3K | -$19.6K | -$84.4K | -$13K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $5.5K | $6K | $23.2K | $99K | $30K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $5.5K | $6K | $23.2K | $99K | $30K | |
Beginning Cash (CF) | $1.6K | $400 | $860 | $4.9K | $2.1K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$250 | -$320 | $3.6K | $14.7K | $17.1K | |
Ending Cash (CF) | $1.4K | $80 | $4.5K | $19.6K | $19.1K | |
Levered Free Cash Flow | -$5.8K | -$6.3K | -$19.6K | -$84.3K | -$12.9K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.